We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoldPlat Regulatory News (GDP)

Share Price Information for GoldPlat (GDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 7.80
Ask: 8.20
Change: 0.00 (0.00%)
Spread: 0.40 (5.128%)
Open: 8.00
High: 8.00
Low: 8.00
Prev. Close: 8.00
GDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of Kilimapesa

4 Jan 2021 08:45

RNS Number : 3955K
Goldplat plc
04 January 2021
 

Goldplat plc / Ticker: GDP / Index: AIM / Sector: Mining & Exploration

 

 

04 January 2021

 

Goldplat plc('Goldplat', the 'Group' or 'the Company')

Update on the sale of Kilimapesa

 

Goldplat plc (“Goldplat”), the AIM quoted gold producer, with international gold recovery operations located in South Africa and Ghana and an a held for sale underground mining operation in Kenya, is pleased to provide an update on the sale of Kilimapesa.

 

As announced on 31 July 2020, it has been conditionally agreed by Goldplat's subsidiary Gold Mineral Resources Ltd ("GMR") to sell Kilimapesa to Mayflower Capital Investments Pty Limited ("Mayflower") for an initial consideration of USD1,500,000 to be satisfied by the issue of shares to that value in Mayflower and that Mayflower has separately entered into an agreement under which it will assign its rights and obligations under the term sheet to Papillon Holdings plc (LSE: PPHP) ("Papillon"), which is listed on the standard segment of London Stock Exchange and which will, subject to the appropriate regulatory and shareholder approvals, seek to complete the acquisition and raise a minimum USD4,000,000 of funding for the development of Kilimapesa's operations.

 

The terms of the agreement between the Company's subsidiary, Gold Mineral Resources Pty Limited ("GMR") and Mayflower are subject to a number of conditions precedent including the completion of due diligence being conducted by both Mayflower and GMR, the receipt of all necessary approvals, the finalising of formal agreements and the raising of equity by Papillon of at least USD4,000,000.

 

As announced on 1 October 2020, the term sheet was extended to 31 December 2020 based on certain conditions. The parties have now agreed to extend the term sheet and exclusivity period again, from 31 December 2020 to 28 February 2021. The value of the consideration shares to be issued has been increased from USD1,500,000 to USD1,750,000, and an option that can be exercised by Mayflower has been included for considerationto be paid in cash of USD1,500,000 rather than shares. The extension is also dependent on Papillion creditor deeds being executed by 15 January 2021, a majority of Papillon shareholders confirming pre-approval of the proposed reverse takeover by 20 January 2021 and GMR to being put in a position to complete due diligence by 25 January 2021.

 

To date, from signing of initial terms Mayflower has supported Kilimapesa with a subordinated loan of USD400,000 and has committed to support Kilimapesa with a further USD100,000, if required, before completion of transaction.

 

Werner Klingenberg, CEO of Goldplat commented: "Both parties are encouraged with the steady progress made, albeit slower than originally expected, due to delays outside both parties control and Goldplat remains confident in Mayflower's ability to complete transaction. We continue to receive the benefit of the Mayflower management team at Kilimapesa.

 

For further information visit www.goldplat.com, follow on Twitter @GoldPlatPlc or contact:

 

Werner Klingenberg

 

Goldplat plc

(CEO)

 

Tel: +27 (0) 82 051 1071

Colin Aaronson / Harrison Clarke/Seamus Fricker

 

Grant Thornton UK LLP

(Nominated Adviser)

Tel: +44 (0) 20 7383 5100

 

James Joyce / Jessica Cave

 

WH Ireland Limited

(Broker)

 

Tel: +44 (0) 207 220 1666

 

Tim Thompson / Mark Edwards / Fergus Mellon

Flagstaff Strategic and Investor Communications

Tel: +44 (0) 207 129 1474

goldplat@flagstaffcomms.com

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUSVARAUUARRR
Date   Source Headline
20th Aug 202112:48 pmRNSUpdate on Kilimapesa
6th Aug 20212:40 pmRNSExercise of Options and Total Voting Rights
5th Aug 20217:00 amRNSQuarterly Update - Update on 12 months 30 June 21
30th Jul 20217:00 amRNSTotal Voting Rights
23rd Jul 20212:57 pmRNSExercise of Options
20th Jul 20219:38 amRNSReplacement:Update on consideration for Kilimapesa
20th Jul 20217:08 amRNSUpdate on Consideration Receivable for Kilimapesa
20th Jul 20217:00 amRNSCorporate Transactions and Dividend Policy
19th Jul 20217:00 amRNSUpdate on consideration receivable for Kilimapesa
17th May 20217:00 amRNSUpdate on the nine months ended 31 March 2021
26th Apr 20217:00 amRNSCompletion of Sale of Kilimapesa Gold (Pty) Ltd
1st Apr 202110:00 amRNSUpdate on Sale of Kilimapesa
30th Mar 20217:00 amRNSResignation of Director
16th Mar 20211:18 pmRNSReplacement: Interim Results 31 Dec 20
12th Mar 20214:42 pmRNSInterim Results for the six months ended 31 Dec 21
11th Mar 20217:00 amRNSUpdate on sale of Kilimapesa
5th Mar 20217:00 amRNSInterim Results for the six months ended 31 Dec 20
2nd Mar 20217:00 amRNSUpdates on Group Structure and Interim Results
23rd Feb 20217:00 amRNSUpdate on sale of Kilimapesa
19th Feb 20218:24 amRNSUpdate on the Simplifying Group Structure
18th Feb 20217:38 amRNSUpdate on sale of Kilimapesa
15th Feb 20217:00 amRNSSimplifying Group Structure to Reduce Group Costs
8th Feb 20217:00 amRNSUpdate on six months ended 31 December 2020
22nd Jan 20217:00 amRNSLondon South East Investor Webinar
4th Jan 20218:45 amRNSUpdate on Sale of Kilimapesa
31st Dec 20201:23 pmRNSResult of AGM / Directorate Change
30th Dec 20207:15 amRNSNotice of Investor and Analyst Conference Call
9th Dec 20207:00 amRNSNotice of Investor and Analyst Conference Call
7th Dec 202011:46 amRNSPosting of Annual Report and Notice of AGM
30th Nov 20207:00 amRNSPreliminary Unaudited Results for YE 30 Jun 2020
11th Nov 202012:51 pmRNSUpdate on Preliminary Results & Sale of Kilimapesa
26th Oct 20207:17 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSQuarterly Update - Q1 Ended 30 Sept 2020
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:36 pmRNSPrice Monitoring Extension
15th Oct 20207:00 amRNSUpdate on preliminary results & Sale of Kilimapesa
1st Oct 20207:00 amRNSUpdate - Preliminary Results & Sale of Kilimapesa
18th Sep 20207:05 amRNSUpdate on sale of Kilimapesa Pty Limited
3rd Sep 20207:12 amRNSUpdate on the sale of Kilimapesa Pty Limited
26th Aug 20207:32 amRNSHolding(s) in Company
4th Aug 20208:16 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSSigning of term sheet for sale of Kilimapesa Gold
28th Jul 20207:00 amRNSQuarterly Operational Update - Q4 30 June 2020
15th Jul 20204:16 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSExercise of Options
26th Jun 202012:57 pmRNSDirector/PDMR Shareholding
21st May 202010:03 amRNSHolding(s) in Company
14th May 202010:47 amRNSAppointment of Non-executive Director
28th Apr 20208:53 amRNSQuarterly Operational Update - Q3 31 March 2020
17th Apr 202011:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.